Top ▲
target has curated data in GtoImmuPdb
Target id: 1470
Nomenclature: G protein-coupled receptor kinase 6
Abbreviated Name: GRK6
Family: GRK4 subfamily
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 576 | 5q35.3 | GRK6 | G protein-coupled receptor kinase 6 | |
Mouse | - | 576 | 13 30.06 cM | Grk6 | G protein-coupled receptor kinase 6 | |
Rat | - | 576 | 17p14 | Grk6 | G protein-coupled receptor kinase 6 |
Previous and Unofficial Names |
GPRK6 |
Database Links | |
Alphafold | P43250 (Hs), O70293 (Mm), P97711 (Rn) |
BRENDA | 2.7.11.16 |
ChEMBL Target | CHEMBL6144 (Hs) |
Ensembl Gene | ENSG00000198055 (Hs), ENSMUSG00000074886 (Mm), ENSRNOG00000014615 (Rn) |
Entrez Gene | 2870 (Hs), 26385 (Mm), 59076 (Rn) |
Human Protein Atlas | ENSG00000198055 (Hs) |
KEGG Enzyme | 2.7.11.16 |
KEGG Gene | hsa:2870 (Hs), mmu:26385 (Mm), rno:59076 (Rn) |
OMIM | 600869 (Hs) |
Pharos | P43250 (Hs) |
RefSeq Nucleotide | NM_001004105 (Hs), NM_001112711 (Mm), NM_001112712 (Rn) |
RefSeq Protein | NP_001004105 (Hs), NP_001106182 (Mm), NP_001033107 (Mm), NP_036068 (Mm), NP_001106183 (Rn) |
UniProtKB | P43250 (Hs), O70293 (Mm), P97711 (Rn) |
Wikipedia | GRK6 (Hs) |
Selected 3D Structures | |||||||||||||
|
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service. A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform. http://www.millipore.com/techpublications/tech1/pf3036 http://www.reactionbiology.com/webapps/main/pages/kinase.aspx Reference: 1-2 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: GRK6/GRK6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
Immunopharmacology Comments |
GRK6 expression and activity is downregulated in lymphocytes from RA patients [4] |
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013) A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem J, 451 (2): 313-28. [PMID:23398362]
3. Lodowski DT, Tesmer VM, Benovic JL, Tesmer JJ. (2006) The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs. J Biol Chem, 281 (24): 16785-93. [PMID:16613860]
4. Lombardi MS, Kavelaars A, Schedlowski M, Bijlsma JW, Okihara KL, Van de Pol M, Ochsmann S, Pawlak C, Schmidt RE, Heijnen CJ. (1999) Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J, 13 (6): 715-25. [PMID:10094932]
5. Tesmer JJ, Tesmer VM, Lodowski DT, Steinhagen H, Huber J. (2010) Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol. J Med Chem, 53 (4): 1867-70. [PMID:20128603]
GRK4 subfamily: G protein-coupled receptor kinase 6. Last modified on 07/12/2016. Accessed on 23/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1470.